Axitinib (Inlyta)

Axitinib · Pfizer

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Axitinib (Inlyta), covering 2018-06-08 to 2026-03-02. Get the full timeline:

Most recent: Clinical Trial Update: Study of Axitinib (AG-013736) With Evaluation of the VEGF-pathway in Pheochromocytoma/Paraganglioma [Phase 2]